Viewing Study NCT06389760

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:09 AM
Ignite Modification Date: 2026-01-07 @ 5:51 PM
Study NCT ID: NCT06389760
Status: RECRUITING
Last Update Posted: 2024-10-31
First Post: 2024-04-11
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Nimotuzumab Combined With mFOLFIRINOX/GX as Postoperative Adjuvant Therapy in Pancreatic Cancer
Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pancreatic Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Nimotuzumab View
None mFOLFIRINOX View
None adjuvant therapy View
None pancreatic cancer View
None GX View